Search clinical trials for: RVX000222
Total 10 results
-
Resverlogix CorpThe Cleveland ClinicCompletedCoronary Artery DiseaseNetherlands, Spain, Russian Federation, Belgium, Brazil, Argentina, Poland, Hungary
-
Resverlogix CorpNucleus Network Ltd; Baker Heart and Diabetes InstituteCompleted
-
Resverlogix CorpThe Cleveland ClinicCompletedCoronary Artery Disease | DyslipidemiaSouth Africa
-
Resverlogix CorpWithdrawn
-
Resverlogix CorpCompletedSafety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL CholesterolCardiovascular Disease | Atherosclerosis | Dyslipidemia | Acute Coronary SyndromeUnited States
-
Resverlogix CorpCompletedCoronary Artery Disease | AtherosclerosisUnited States
-
Resverlogix CorpNot yet recruiting
-
Resverlogix CorpNot yet recruitingPost-Acute COVID-19 SyndromeUnited Arab Emirates, Jordan, Saudi Arabia
-
Resverlogix CorpPPD; ICON plc; Medidata SolutionsCompletedCoronary Artery Disease | Diabetes Mellitus, Type 2Netherlands, Taiwan, Argentina, Israel, Poland, Russian Federation, Australia, Belgium, Serbia, Bulgaria, Hungary, Slovakia, Mexico, Croatia, Germany
-
Resverlogix CorpSouth Australian Health and Medical Research InstituteTerminatedCoronary Artery Disease | DyslipidemiaAustralia